131 related articles for article (PubMed ID: 34602434)
21. A comparison of the safety and efficacy of twice daily brimonidine 0.2% versus betaxolol 0.25% in subjects with elevated intraocular pressure. The Brimonidine Study Group III.
Serle JB
Surv Ophthalmol; 1996 Nov; 41 Suppl 1():S39-47. PubMed ID: 8970248
[TBL] [Abstract][Full Text] [Related]
22. Ocular hypotensive efficacy and safety of a combined formulation of betaxolol and pilocarpine.
Robin AL
Trans Am Ophthalmol Soc; 1996; 94():89-101; discussion 101-3. PubMed ID: 8981691
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the clinical success rates and quality of life effects of brimonidine tartrate 0.2% and betaxolol 0.25% suspension in patients with open-angle glaucoma and ocular hypertension. Brimonidine Outcomes Study Group II.
Javitt J; Goldberg I
J Glaucoma; 2000 Oct; 9(5):398-408. PubMed ID: 11039742
[TBL] [Abstract][Full Text] [Related]
24. ADRB1 and ADBR2 gene polymorphisms and the ocular hypotensive response to topical betaxolol in healthy Mexican subjects.
Messina Baas O; Pacheco Cuellar G; Toral-López J; Lara Huerta SF; Gonzalez-Huerta LM; Urueta-Cuellar H; Rivera-Vega MR; Babayan-Mena I; Cuevas-Covarrubias SA
Curr Eye Res; 2014 Nov; 39(11):1076-80. PubMed ID: 24749907
[TBL] [Abstract][Full Text] [Related]
25. Effects of betaxolol and latanoprost on ocular blood flow and visual fields in patients with primary open-angle glaucoma.
Erkin EF; Tarhan S; Kayikçioğlu OR; Deveci H; Güler C; Göktan C
Eur J Ophthalmol; 2004; 14(3):211-9. PubMed ID: 15206646
[TBL] [Abstract][Full Text] [Related]
26. New antiglaucomatous agent for the treatment of open angle glaucoma: Polymeric inserts for drug release and in vitro and in vivo study.
Cesar ALA; Navarro LC; Castilho RO; Goulart GAC; Foureaux G; Ferreira AJ; Cronemberger S; Gomes Faraco AA
J Biomed Mater Res A; 2021 Mar; 109(3):336-345. PubMed ID: 32490596
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of combined administration of 0.2% brimonidine and 0.5% betaxolol in treatment of primary open angle glaucoma and ocular hypertension.
Chi W; Li A; Wang S; Zhu X
Eye Sci; 2013 Dec; 28(4):190-4. PubMed ID: 24961091
[TBL] [Abstract][Full Text] [Related]
28. Ocular Intracameral Pharmacokinetics for a Cocktail of Timolol, Betaxolol, and Atenolol in Rabbits.
Fayyaz A; Ranta VP; Toropainen E; Vellonen KS; Ricci GD; Reinisalo M; Heikkinen EM; Gardner I; Urtti A; Jamei M; Del Amo EM
Mol Pharm; 2020 Feb; 17(2):588-594. PubMed ID: 31794668
[TBL] [Abstract][Full Text] [Related]
29. In situ gelling xyloglucan/alginate liquid formulation for oral sustained drug delivery to dysphagic patients.
Itoh K; Tsuruya R; Shimoyama T; Watanabe H; Miyazaki S; D'Emanuele A; Attwood D
Drug Dev Ind Pharm; 2010 Apr; 36(4):449-55. PubMed ID: 19788404
[TBL] [Abstract][Full Text] [Related]
30. A double-masked, randomized 1-year study comparing dorzolamide (Trusopt), timolol, and betaxolol. International Dorzolamide Study Group.
Strahlman E; Tipping R; Vogel R
Arch Ophthalmol; 1995 Aug; 113(8):1009-16. PubMed ID: 7639651
[TBL] [Abstract][Full Text] [Related]
31. A novel ion-exchange carrier based upon liposome-encapsulated montmorillonite for ophthalmic delivery of betaxolol hydrochloride.
Huang Y; Tao Q; Hou D; Hu S; Tian S; Chen Y; Gui R; Yang L; Wang Y
Int J Nanomedicine; 2017; 12():1731-1745. PubMed ID: 28280338
[TBL] [Abstract][Full Text] [Related]
32. Comparison of thermosensitive in situ gels and drug-resin complex for ocular drug delivery: In vitro drug release and in vivo tissue distribution.
Wei Y; Li C; Zhu Q; Zhang X; Guan J; Mao S
Int J Pharm; 2020 Mar; 578():119184. PubMed ID: 32112932
[TBL] [Abstract][Full Text] [Related]
33. Design, formulation, and evaluation of novel sustain release bioadhesive in-situ gelling ocular inserts of ketorolac tromethamine.
Jethava JK; Jethava GK
Int J Pharm Investig; 2014 Oct; 4(4):226-32. PubMed ID: 25426444
[TBL] [Abstract][Full Text] [Related]
34. A double-masked randomized comparison of the efficacy and safety of unoprostone with timolol and betaxolol in patients with primary open-angle glaucoma including pseudoexfoliation glaucoma or ocular hypertension. 6 month data.
Nordmann JP; Mertz B; Yannoulis NC; Schwenninger C; Kapik B; Shams N;
Am J Ophthalmol; 2002 Jan; 133(1):1-10. PubMed ID: 11755834
[TBL] [Abstract][Full Text] [Related]
35. Sustained release of verapamil hydrochloride from sodium alginate microcapsules.
Farhana SA; Shantakumar SM; Shyale S; Shalam M; Narasu L
Curr Drug Deliv; 2010 Apr; 7(2):98-108. PubMed ID: 20158489
[TBL] [Abstract][Full Text] [Related]
36. Bimatoprost-loaded ocular inserts as sustained release drug delivery systems for glaucoma treatment: in vitro and in vivo evaluation.
Franca JR; Foureaux G; Fuscaldi LL; Ribeiro TG; Rodrigues LB; Bravo R; Castilho RO; Yoshida MI; Cardoso VN; Fernandes SO; Cronemberger S; Ferreira AJ; Faraco AA
PLoS One; 2014; 9(4):e95461. PubMed ID: 24788066
[TBL] [Abstract][Full Text] [Related]
37. Ocular inserts for controlled delivery of pefloxacin mesylate: preparation and evaluation.
Sultana Y; Aqil M; Ali A
Acta Pharm; 2005 Sep; 55(3):305-14. PubMed ID: 16375841
[TBL] [Abstract][Full Text] [Related]
38. Preparation and Evaluation of Nanofibrous and Film-Structured Ciprofloxacin Hydrochloride Inserts for Sustained Ocular Delivery: Pharmacokinetic Study in Rabbit's Eye.
Taghe S; Mirzaeei S; Ahmadi A
Life (Basel); 2023 Mar; 13(4):. PubMed ID: 37109442
[TBL] [Abstract][Full Text] [Related]
39. Incorporation of ion exchange functionalized-montmorillonite into solid lipid nanoparticles with low irritation enhances drug bioavailability for glaucoma treatment.
Liu S; Han X; Liu H; Zhao Y; Li H; D Rupenthal I; Lv Z; Chen Y; Yang F; Ping Q; Pan Y; Hou D
Drug Deliv; 2020 Dec; 27(1):652-661. PubMed ID: 32347126
[TBL] [Abstract][Full Text] [Related]
40. Exploring the gelling properties of Plantago ovata-based Arabinoxylan: Fabrication and optimization of a topical emulgel using response surface methodology.
Mahmood A; Erum A; Tulain UR; Malik NS; Saleem A; Alqahtani MS; Malik MZ; Siddiqui M; Safdar A; Malik A
PLoS One; 2023; 18(8):e0290223. PubMed ID: 37607173
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
